116 related articles for article (PubMed ID: 38226993)
61. The incidence and clinical impact of bone metastases in non-small cell lung cancer.
Kuchuk M; Kuchuk I; Sabri E; Hutton B; Clemons M; Wheatley-Price P
Lung Cancer; 2015 Aug; 89(2):197-202. PubMed ID: 26003503
[TBL] [Abstract][Full Text] [Related]
62. Maspin reduces prostate cancer metastasis to bone.
Hall DC; Johnson-Pais TL; Grubbs B; Bernal R; Leach RJ; Padalecki SS
Urol Oncol; 2008; 26(6):652-8. PubMed ID: 18367129
[TBL] [Abstract][Full Text] [Related]
63. The incidence, risk factors and predictive nomograms for early death of lung cancer with synchronous brain metastasis: a retrospective study in the SEER database.
Shen H; Deng G; Chen Q; Qian J
BMC Cancer; 2021 Jul; 21(1):825. PubMed ID: 34271858
[TBL] [Abstract][Full Text] [Related]
64. Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment.
Kfoury Y; Baryawno N; Severe N; Mei S; Gustafsson K; Hirz T; Brouse T; Scadden EW; Igolkina AA; Kokkaliaris K; Choi BD; Barkas N; Randolph MA; Shin JH; Saylor PJ; Scadden DT; Sykes DB; Kharchenko PV;
Cancer Cell; 2021 Nov; 39(11):1464-1478.e8. PubMed ID: 34719426
[TBL] [Abstract][Full Text] [Related]
65. Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets.
Gong J; Hu S; Shan Q; Qin J; Han N; Xie F; Lu H
Ther Adv Med Oncol; 2024; 16():17588359241239293. PubMed ID: 38510678
[TBL] [Abstract][Full Text] [Related]
66. Colony-stimulating factor 1 potentiates lung cancer bone metastasis.
Hung JY; Horn D; Woodruff K; Prihoda T; LeSaux C; Peters J; Tio F; Abboud-Werner SL
Lab Invest; 2014 Apr; 94(4):371-81. PubMed ID: 24468794
[TBL] [Abstract][Full Text] [Related]
67. The molecular impact of pigment epithelium-derived factor, PEDF, on lung cancer cells and the clinical significance.
Chen J; Ye L; Zhang L; Jiang WG
Int J Oncol; 2009 Jul; 35(1):159-66. PubMed ID: 19513563
[TBL] [Abstract][Full Text] [Related]
68. Bone metastasis model with multiorgan dissemination of human small-cell lung cancer (SBC-5) cells in natural killer cell-depleted SCID mice.
Miki T; Yano S; Hanibuchi M; Sone S
Oncol Res; 2000; 12(5):209-17. PubMed ID: 11417746
[TBL] [Abstract][Full Text] [Related]
69. Zinc finger E-box binding homeobox 1 promotes invasion and bone metastasis of small cell lung cancer in vitro and in vivo.
Liu Y; Zhang N; Wang Y; Xu M; Liu N; Pang X; Cao J; Ma N; Pang H; Liu L; Zhang H
Cancer Sci; 2012 Aug; 103(8):1420-8. PubMed ID: 22632166
[TBL] [Abstract][Full Text] [Related]
70. Proteomics-based Model for Predicting the Risk of Brain Metastasis in Patients with Resected Lung Adenocarcinoma carrying the EGFR Mutation.
Deng Q; Wang F; Song L; Chen L; Huang Y; Guo Z; Yang H
Int J Med Sci; 2024; 21(4):765-774. PubMed ID: 38464823
[No Abstract] [Full Text] [Related]
71. Cathepsin F and Fibulin-1 as novel diagnostic biomarkers for brain metastasis of non-small cell lung cancer.
Wei S; Liu W; Xu M; Qin H; Liu C; Zhang R; Zhou S; Li E; Liu Z; Wang Q
Br J Cancer; 2022 Jun; 126(12):1795-1805. PubMed ID: 35217799
[TBL] [Abstract][Full Text] [Related]
72. Metformin Reduces Thyroid Cancer Tumor Growth in the Metastatic Niche of Bone by Inhibiting Osteoblastic RANKL Productions.
Shin HS; Sun HJ; Whang YM; Park YJ; Park DJ; Cho SW
Thyroid; 2021 May; 31(5):760-771. PubMed ID: 32791889
[No Abstract] [Full Text] [Related]
73. [Establishing the nude mice bone metastasis model of lung adenocarcinoma and applying MicroCT into the observation].
Cui Y; Geng Q; Gu A; Zhu M; Kong H; Sun L; Liu L; Yan M; Yao M
Zhongguo Fei Ai Za Zhi; 2013 Sep; 16(9):452-9. PubMed ID: 24034991
[TBL] [Abstract][Full Text] [Related]
74. Analysis of survival benefit from primary tumor resection and individualized prediction of overall survival for lung cancer patients with bone metastasis: Worth it or not?
Tong Y; Jiang L; Gong Y; Zhu D; Zhao D
Asian J Surg; 2024 Jan; 47(1):333-349. PubMed ID: 37741753
[TBL] [Abstract][Full Text] [Related]
75. Targeted sequencing reveals distinct pathogenic variants in Chinese patients with lung adenocarcinoma brain metastases.
Ma Y; Chen K; Yang Z; Guan M
Oncol Lett; 2018 Apr; 15(4):4503-4510. PubMed ID: 29541220
[TBL] [Abstract][Full Text] [Related]
76. Identification of genes potentially involved in bone metastasis by genome-wide gene expression profile analysis of non-small cell lung cancer in mice.
Dat le T; Matsuo T; Yoshimaru T; Kakiuchi S; Goto H; Hanibuchi M; Kuramoto T; Nishioka Y; Sone S; Katagiri T
Int J Oncol; 2012 May; 40(5):1455-69. PubMed ID: 22294041
[TBL] [Abstract][Full Text] [Related]
77. Design of human granzyme B variants resistant to serpin B9.
Losasso V; Schiffer S; Barth S; Carloni P
Proteins; 2012 Nov; 80(11):2514-22. PubMed ID: 22733450
[TBL] [Abstract][Full Text] [Related]
78. STAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activation.
Singh M; Garg N; Venugopal C; Hallett R; Tokar T; McFarlane N; Mahendram S; Bakhshinyan D; Manoranjan B; Vora P; Qazi M; Arpin CC; Page B; Haftchenary S; Rosa DA; Lai PS; Gómez-Biagi RF; Ali AM; Lewis A; Geletu M; Murty NK; Hassell JA; Jurisica I; Gunning PT; Singh SK
Oncotarget; 2015 Sep; 6(29):27461-77. PubMed ID: 26314961
[TBL] [Abstract][Full Text] [Related]
79. Targeting c-Jun Is a Potential Therapy for Luminal Breast Cancer Bone Metastasis.
Han Y; Katayama S; Futakuchi M; Nakamichi K; Wakabayashi Y; Sakamoto M; Nakayama J; Semba K
Mol Cancer Res; 2023 Sep; 21(9):908-921. PubMed ID: 37310848
[TBL] [Abstract][Full Text] [Related]
80. Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration.
Feeley BT; Liu NQ; Conduah AH; Krenek L; Roth K; Dougall WC; Huard J; Dubinett S; Lieberman JR
J Bone Miner Res; 2006 Oct; 21(10):1571-80. PubMed ID: 16995812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
